The Annexure

News to 9 October 2026 ·

What the ground filed.

A desk of BSE disclosures — every listed company, sliced the way you need it.

Data as of 9 October 2026

Acquisition

Board of Directors have approved the acquisition of equity shares of step down subsidiary company as per details enclosed.

The filing

Board of Directors have approved the acquisition of equity shares of step down subsidiary company as per details enclosed.

Company
Acutaas Chemicals Ltd · BSE 543349
Filed
24 September 2026, 19:36 IST
BSE category
Company Update / Acquisition
Tag
Acquisition · selected
Source
Open the filing on BSE →

Why it led

  • First Acquisition from this company — not seen in the 93 trading days on record
  • Mid cap · NIFTY 500

Selected by the ranker from 42 filings that day. Each line above is a component of that score, not a comment on the filing.

How often this tag appears

505 of 90,553 filings in the published window carry Acquisition · 0.56%

Around it

Also filed by Acutaas Chemicals Ltd on 24 September 2026

Most recent filings from Acutaas Chemicals Ltd

The company

Acutaas Chemicals Ltd

BSE 543349 · NSE ACUTAAS · ISIN INE00FF01025 · Group A · Active

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

Full figures, price and filing history for Acutaas Chemicals Ltd →